Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue 6
Submit an article Journal homepage
2,693
Views
55
CrossRef citations to date
0
Altmetric
Reviews

The therapeutic application of CRISPR/Cas9 technologies for HIV

Sheena SaaymanThe Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA;University of the Witwatersrand, Department of Molecular Medicine and Haematology, HIV Pathogenesis Research Unit, 7 York Road, Parktown, 2193, South Africa
,
Stuart A AliUniversity of the Witwatersrand, Department of Molecular Medicine and Haematology, HIV Pathogenesis Research Unit, 7 York Road, Parktown, 2193, South Africa
,
Kevin V MorrisThe Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA;The University of New South Wales, School of Biotechnology and Biomolecular Medicine, Sydney, NSW 2052, Australia
&
Marc S WeinbergThe Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA;University of the Witwatersrand, Department of Molecular Medicine and Haematology, HIV Pathogenesis Research Unit, 7 York Road, Parktown, 2193, South Africa;University of the Witwatersrand, Department of Molecular Medicine and Haematology, Antiviral Gene Therapy Research Unit, 7 York Road, Parktown, 2193, South [email protected]
Pages 819-830 | Published online: 12 Apr 2015

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maude Loignon & Emil Toma. (2016) Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions. Expert Review of Anti-infective Therapy 14:2, pages 177-191.
Read now

Articles from other publishers (54)

Alyona Sorokina, Elizaveta Anchakova & Erdem Dashinimaev. (2023) Strategies for HIV-1 suppression through key genes and cell therapy. Frontiers in Medicine 10.
Crossref
Yimin Du, Yanfei Liu, Jiaxin Hu, Xingxing Peng & Zhenbao Liu. (2023) CRISPR/Cas9 systems: Delivery technologies and biomedical applications. Asian Journal of Pharmaceutical Sciences 18:6, pages 100854.
Crossref
Yehya Khlidj. (2023) What did CRISPR-Cas9 accomplish in its first 10 years?. Biochemia Medica 33:3.
Crossref
Seyed Esmaeil Ahmadi, Maral Soleymani, Fahimeh Shahriyary, Mohammad Reza Amirzargar, Mahya Ofoghi, Mohammad Davood Fattahi & Majid Safa. (2023) Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy. Cancer Gene Therapy 30:7, pages 936-954.
Crossref
N. S. Pokrovsky, M. A. Vodyakova, E. V. Melnikova & V. A. Merkulov. (2023) Development of Medicinal Products Based on Gene-Editing Technology: Regulatory Practices. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation 13:2-1, pages 248-260.
Crossref
Shuai Zhen, Hong Chen, Jiaojiao Lu, Xiling Yang, Xiaoqian Tuo, Shixue Chang, Yuhan Tian & Xu Li. (2023) Intravaginal delivery for CRISPR–Cas9 technology: For example, the treatment of HPV infection. Journal of Medical Virology 95:2.
Crossref
Akash Kumaran, Nathan Jude Serpes, Tisha Gupta, Abija James, Avinash Sharma, Deepak Kumar, Rupak Nagraik, Vaneet Kumar & Sadanand Pandey. (2023) Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application. Biosensors 13:2, pages 202.
Crossref
Michaela A. Boti, Konstantina Athanasopoulou, Panagiotis G. Adamopoulos, Diamantis C. Sideris & Andreas Scorilas. (2023) Recent Advances in Genome-Engineering Strategies. Genes 14:1, pages 129.
Crossref
Davi Silva SantanaMarcos Jessé Abrahão Silva, Ana Beatriz Rocha de MarinVanessa Ladyanne da Silva CostaGabriel Silas Marinho SousaJuliana Gonçalves de SousaDihago Cardoso SilvaEliete Costa da CruzLuana Nepomuceno Gondim Costa Lima. (2023) The Influence Between C-C Chemokine Receptor 5 Genetic Polymorphisms and the Type-1 Human Immunodeficiency Virus: A 20-Year Review . AIDS Research and Human Retroviruses 39:1, pages 13-32.
Crossref
Ruchira Bhowmik & Binay Chaubey. (2022) CRISPR/Cas9: a tool to eradicate HIV-1. AIDS Research and Therapy 19:1.
Crossref
Sadegh Shojaei Baghini, Zhanna R. Gardanova, Saeme Azizi Hassan Abadi, Burhan Abdullah Zaman, Ahmet İlhan, Navid Shomali, Ali Adili, Roozbeh Moghaddar & Amirhossein Fakhre Yaseri. (2022) CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool. Cellular & Molecular Biology Letters 27:1.
Crossref
Amit Khurana, Nilofer Sayed, Vishakha Singh, Isha Khurana, Prince Allawadhi, Pushkar Singh Rawat, Umashanker Navik, Sravan Kumar Pasumarthi, Kala Kumar Bharani & Ralf Weiskirchen. (2022) A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery. Journal of Cellular Biochemistry 123:10, pages 1674-1698.
Crossref
Sajad Najafi, Shing Cheng Tan, Shahin Aghamiri, Pourya Raee, Zahra Ebrahimi, Zahra Kargar Jahromi, Yazdan Rahmati, Javid Sadri Nahand, Ahmad Piroozmand, Vahid Jajarmi & Hamed Mirzaei. (2022) Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections. Biomedicine & Pharmacotherapy 148, pages 112743.
Crossref
Huimin Zhang, Chunhong Qin, Changming An, Xiwang Zheng, Shuxin Wen, Wenjie Chen, Xianfang Liu, Zhenghua Lv, Pingchang Yang, Wei Xu, Wei Gao & Yongyan Wu. (2021) Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Molecular Cancer 20:1.
Crossref
Haisi Dong, Zeyu Wang, Daqing Zhao, Xiangyang Leng & Yicheng Zhao. (2021) Antiviral strategies targeting herpesviruses. Journal of Virus Eradication 7:3, pages 100047.
Crossref
Hashanthi K. Abeyratne-Perera, Saswati Basu & Preethi L. Chandran. (2021) Shells of compacted DNA as nanocontainers transporting proteins in multiplexed delivery. Materials Science and Engineering: C 127, pages 112184.
Crossref
Anindya Roy Chowdhury & Gouri Gargate. (2021) The trends in CRISPR research: A patent and literature study with a focus on India. World Patent Information 65, pages 102038.
Crossref
Tristan A. Scott, Denis O’Meally, Nicole Anne Grepo, Citradewi Soemardy, Daniel C. Lazar, Yue Zheng, Marc S. Weinberg, Vicente Planelles & Kevin V. Morris. (2021) Broadly active zinc finger protein-guided transcriptional activation of HIV-1. Molecular Therapy - Methods & Clinical Development 20, pages 18-29.
Crossref
Guillaume Clavé, Maeva Reverte, Jean-Jacques Vasseur & Michael Smietana. (2021) Modified internucleoside linkages for nuclease-resistant oligonucleotides. RSC Chemical Biology 2:1, pages 94-150.
Crossref
Xuanting Tang. (2021) CRISPR/Cas9-based genome engineering in HIV gene therapy. E3S Web of Conferences 233, pages 02004.
Crossref
Pedro R.L. Perdigão, Catarina Cunha-Santos, Carlos F. BarbasIIIIII, Mariana Santa-Marta & Joao Goncalves. (2020) Protein Delivery of Cell-Penetrating Zinc-Finger Activators Stimulates Latent HIV-1-Infected Cells. Molecular Therapy - Methods & Clinical Development 18, pages 145-158.
Crossref
V. Kalidasan & Kumitaa Theva Das. (2020) Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?. Frontiers in Microbiology 11.
Crossref
Lu Wen, Qiang Liu, Jingjing Xu, Xixi Liu, Chaoyi Shi, Zuwei Yang, Yili Zhang, Hong Xu, Jiang Liu, Hui Yang, Hefeng Huang, Jie Qiao, Fuchou Tang & Zi-Jiang Chen. (2019) Recent advances in mammalian reproductive biology. Science China Life Sciences 63:1, pages 18-58.
Crossref
Maria João Almeida & Ana Matos. (2019) Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV. Current HIV Research 17:5, pages 306-323.
Crossref
Luqman Jubair, Sora Fallaha & Nigel A.J. McMillan. (2019) Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors. Molecular Therapy 27:12, pages 2091-2099.
Crossref
Viktor Limanskiy, Arpita Vyas, Lakshmi Shankar Chaturvedi & Dinesh Vyas. (2019) Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World Journal of Gastroenterology 25:18, pages 2177-2187.
Crossref
Subbroto Kumar Saha, Forhad Karim Saikot, Md. Shahedur Rahman, Mohammad Abu Hena Mostofa Jamal, S.M. Khaledur Rahman, S.M. Riazul Islam & Ki-Hyun Kim. (2019) Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech. Molecular Therapy - Nucleic Acids 14, pages 212-238.
Crossref
Ilaria Furlan, Ivana Domljanovic, Jesper Uhd & Kira Astakhova. (2018) Improving the Design of Synthetic Oligonucleotide Probes by Fluorescence Melting Assay. ChemBioChem 20:4, pages 587-594.
Crossref
Soumyashree A. Gangopadhyay, Kurt J. Cox, Debasish Manna, Donghyun Lim, Basudeb Maji, Qingxuan Zhou & Amit Choudhary. (2019) Precision Control of CRISPR-Cas9 Using Small Molecules and Light. Biochemistry 58:4, pages 234-244.
Crossref
Yonggang Zhang, Gustavo Arango, Fang Li, Xiao Xiao, Raj Putatunda, Jun Yu, Xiao-Feng Yang, Hong Wang, Layne T. Watson, Liqing Zhang & Wenhui Hu. (2018) Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling. BMC Medical Genomics 11:1.
Crossref
Todd Hulgan, Chandravanu Dash, David W Haas & Elizabeth J Phillips. (2018) Precision HIV care: responding to old questions and meeting new challenges. Pharmacogenomics 19:17, pages 1299-1302.
Crossref
Qiudi Deng, Zisheng Chen, Lei Shi & Huafeng Lin. (2018) Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection. Reviews in Medical Virology 28:5, pages e1998.
Crossref
Yan‐Dong Tang, Jin‐Chao Guo, Tong‐Yun Wang, Kuan Zhao, Ji‐Ting Liu, Jia‐Cong Gao, Zhi‐Jun Tian, Tong‐Qing An & Xue‐Hui Cai. (2018) CRISPR/Cas9‐mediated 2‐sgRNA cleavage facilitates Pseudorabies virus editing. The FASEB Journal 32:8, pages 4293-4301.
Crossref
Chuan Dong, Ge-Fei Hao, Hong-Li Hua, Shuo Liu, Abraham Alemayehu Labena, Guoshi Chai, Jian Huang, Nini Rao & Feng-Biao Guo. (2018) Anti-CRISPRdb: a comprehensive online resource for anti-CRISPR proteins. Nucleic Acids Research 46:D1, pages D393-D398.
Crossref
Vijai Singh, Nisarg Gohil, Robert Ramírez García, Darren Braddick & Christian Kuete Fofié. (2017) Recent Advances in CRISPR‐Cas9 Genome Editing Technology for Biological and Biomedical Investigations. Journal of Cellular Biochemistry 119:1, pages 81-94.
Crossref
Christian Schwartz, Sophie Bouchat, Céline Marban, Virginie Gautier, Carine Van Lint, Olivier Rohr & Valentin Le Douce. (2017) On the way to find a cure: Purging latent HIV-1 reservoirs. Biochemical Pharmacology 146, pages 10-22.
Crossref
Braira WahidSana UsmanAmjad AliKomal SaleemShazia RafiqueZara Naz, Hafiz Ahsan AshfaqMuhammad Idrees. (2017) Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections. Viral Immunology 30:8, pages 552-559.
Crossref
Mayra A. Carrillo, Anjie Zhen, Jerome A. Zack & Scott G. Kitchen. (2017) New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV. Translational Research 187, pages 83-92.
Crossref
Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek & Zhenfeng Duan. (2017) Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells. Oncotarget 8:18, pages 30276-30287.
Crossref
Hafiza Fizzah Zulfiqar, Aneeqa Javed, Sumbal, Bakht Afroze, Qurban AliAliAli, Khadija Akbar, Tariq Nadeem, Muhammad Adeel Rana, Zaheer Ahmad Nazar, Idrees Ahmad Nasir & Tayyab Husnain. (2017) HIV Diagnosis and Treatment through Advanced Technologies. Frontiers in Public Health 5.
Crossref
Anita Le HeronSteven PattersonRafael J. Yáñez-MuñozGeorge Dickson. (2017) Chimeric Trojan Protein Insertion in Lentiviral Membranes Makes Lentiviruses Susceptible to Neutralization by Anti-Tetanus Serum Antibodies. Human Gene Therapy 28:3, pages 242-254.
Crossref
Vijai Singh, Darren Braddick & Pawan Kumar Dhar. (2017) Exploring the potential of genome editing CRISPR-Cas9 technology. Gene 599, pages 1-18.
Crossref
James E. DiCarlo, Anurag Deeconda & Stephen H. Tsang. 2017. Precision Medicine, CRISPR, and Genome Engineering. Precision Medicine, CRISPR, and Genome Engineering 3 27 .
Yunlong Huang & Jialin Zheng. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology 261 283 .
Yi-ying Chou, Annabel Krupp, Campbell Kaynor, Raphaël Gaudin, Minghe Ma, Ellen Cahir-McFarland & Tom Kirchhausen. (2016) Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9. Scientific Reports 6:1.
Crossref
Sivan Tamir. (2016) Postnatal Human Genetic Enhancement – A Consideration of Children’s Right to Be Genetically Enhanced. Frontiers in Sociology 1.
Crossref
Marc S. Weinberg & Kevin V. Morris. (2016) Transcriptional gene silencing in humans. Nucleic Acids Research 44:14, pages 6505-6517.
Crossref
Chunxia Qi, Xiaopeng Jia, Lingling Lu, Ping Ma & Min Wei. (2016) HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation. PLOS ONE 11:4, pages e0152975.
Crossref
Katherine Luzuriaga. (2016) Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children. Annual Review of Medicine 67:1, pages 201-213.
Crossref
Matthew Porteus. (2016) Genome Editing: A New Approach to Human Therapeutics. Annual Review of Pharmacology and Toxicology 56:1, pages 163-190.
Crossref
Chao Liu, Xiancai Ma, Bingfeng Liu, Cancan Chen & Hui Zhang. (2015) HIV-1 functional cure: will the dream come true?. BMC Medicine 13:1.
Crossref
Yonggang Zhang, Chaoran Yin, Ting Zhang, Fang Li, Wensheng Yang, Rafal Kaminski, Philip Regis Fagan, Raj Putatunda, Won-Bin Young, Kamel Khalili & Wenhui Hu. (2015) CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Scientific Reports 5:1.
Crossref
Cheng Peng, Mengji Lu & Dongliang Yang. (2015) CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV. Virologica Sinica 30:5, pages 317-325.
Crossref
Anke Wagner, Claus-Thomas Bock, Henry Fechner & Jens Kurreck. (2015) Application of modified antisense oligonucleotides and siRNAs as antiviral drugs. Future Medicinal Chemistry 7:13, pages 1637-1642.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.